Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK8-IN-9 (compound 22) is a potent inhibitor of type II CDK8 (IC50: 48.6 nM) and has shown inhibitory effects on tumour growth. CDK8-IN-9 can be used to study colorectal cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | CDK8-IN-9 (compound 22) is a potent inhibitor of type II CDK8 (IC50: 48.6 nM) and has shown inhibitory effects on tumour growth. CDK8-IN-9 can be used to study colorectal cancer. |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.